U of M experts lead the way in breast cancer treatment, research and awareness
October 24, 2012
This October, as patients, families, friends and supporters mark Breast Cancer Awareness Month, researchers and physicians at the University of Minnesota’s Masonic Cancer Center are doing the same.
The following University of Minnesota breast cancer experts can share their knowledge and expertise on breast cancer related stories.
Douglas Yee, M.D., director of the Masonic Cancer Center, professor in the Medical School and School of Pharmacology
Yee focuses research on improving breast cancer treatment by understanding and targeting the key components of the insulin-like growth factor (IGF) system. He can also speak to many of the current trends in breast cancer treatment, including mastectomy and its relationship with the return of cancer cells, dividing breast cancers by genetic factors, and common medications. He is a practicing physician at the Breast Center.
Todd Tuttle, M.D., M.S., chief of Surgical Oncology and professor in the Department of Surgery
Tuttle’s research interests include radiofrequency ablation of breast cancer, hyperthermic intraperitoneal chemotherapy and partial breast radiation. He is a practicing oncological surgeon at the Breast Center.
Beth Virnig, Ph.D., professor and associate dean for research in the School of Public Health
Virnig’s research focuses on patterns of and access to cancer care, racial disparities in cancer treatment, ductal carcinoma in situ (DCIS) diagnosis and treatment, as well as population-based research.
Michael Nelson, M.D., professor of Radiology, University of Minnesota Medical School
Nelson is a clinical investigator for the Center for Magnetic Resonance Research (CMRR) and uses magnetic resonance imaging (MRI) for breast cancer diagnosis and measures therapeutic response with magnetic resonance spectroscopy (MRS). He is heavily involved in the I-SPY 1 and I-SPY 2 national clinical trials, for which the University of Minnesota is one of the research sites.
Anne Blaes, M.D., assistant professor in the Medical School
Blaes is a medical hematologist and oncologist, educator and researcher at the University of Minnesota who studies the late effects of cancer treatment, and the impact of treatment on vascular health and quality of life.
Patrick Bolan, Ph.D., assistant professor in the Department of Radiology, University of Minnesota Medical School
Bolan’s expertise lies in developing and assessing new MRI techniques for use in cancer, especially breast cancer, as well as newly developing imaging methods.
David Potter, M.D., Ph.D., associate professor in the Department of Medicine, University of Minnesota Medical School
Potter is a researcher focusing primarily on the impact of diet and diabetes on breast cancer. He has a Susan G. Komen for the Cure funded clinical trial of the HIV protease inhibitor ritonavir in early breast cancer. He is also interested in novel investigational agents for treatment of recurrent/metastatic breast cancer.
To schedule an interview with any of these experts, contact Caroline Marin, Academic Health Center, 612-624-5680, email@example.com